UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2008, ISBN 9780199225859, xvii, 516
Book
2001, Infectious disease and therapy, ISBN 9780824704612, Volume 25, xi, 310
Book
1995, Medical ethics series, ISBN 9780253326195, 193
Book
1991, ISBN 0309044901, viii, 73
Book
2006, ISBN 9780955166907
eBook
1991, ISBN 0309044863, viii, 352
Book
1998, Blackwell companions to philosophy., ISBN 0631197370, xv, 512
Book
1995, ISBN 0309053293, xi, 334
Book
1996, Medicine and society, ISBN 0520214455, Volume 7, xiii, 466
Book
10.
Full Text
Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib
Blood, ISSN 0006-4971, 11/2017, Volume 130, Issue 21, pp. 2307 - 2316
Immunologic Deficiency Syndromes - pathology | Chemokines - blood | Demography | Lymph Nodes - pathology | Class I Phosphatidylinositol 3-Kinases - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Child, Preschool | Pyridines - pharmacokinetics | Infant | Male | Spleen - drug effects | Class I Phosphatidylinositol 3-Kinases - immunology | Molecular Targeted Therapy | Dose-Response Relationship, Drug | TOR Serine-Threonine Kinases - antagonists & inhibitors | Transfection | T-Lymphocytes - drug effects | Female | Lymph Nodes - drug effects | Immunologic Deficiency Syndromes - immunology | Spleen - pathology | Child | Immunologic Deficiency Syndromes - enzymology | Organ Size | Rats | Pyrimidines - pharmacology | Mutation - genetics | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Phenotype | Animals | Immunoglobulin M - blood | Lymphocyte Activation - drug effects | Pyrimidines - pharmacokinetics | T-Lymphocytes - immunology | Immunologic Deficiency Syndromes - drug therapy | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Index Medicus | Abridged Index Medicus | 100 | Immunobiology and Immunotherapy
Journal Article
Haematologica (Roma), ISSN 0390-6078, 07/2015, Volume 100, Issue 7, pp. 978 - 988
Life Sciences & Biomedicine | Hematology | Science & Technology | Lymphohistiocytosis, Hemophagocytic - pathology | Humans | Child, Preschool | Lymphoproliferative Disorders - complications | Male | Virus Diseases - complications | Virus Diseases - drug therapy | T-Lymphocytes - drug effects | Opportunistic Infections - immunology | Immunologic Deficiency Syndromes - immunology | Child | Infant, Newborn | Lymphohistiocytosis, Hemophagocytic - immunology | Opportunistic Infections - complications | Leishmaniasis - immunology | Virus Diseases - immunology | Bacterial Infections - drug therapy | Lymphohistiocytosis, Hemophagocytic - drug therapy | Europe | Lymphohistiocytosis, Hemophagocytic - diagnosis | Terminology as Topic | Leishmaniasis - drug therapy | Immunoglobulins, Intravenous - therapeutic use | Adolescent | Mycoses - drug therapy | T-Lymphocytes - immunology | Immunologic Deficiency Syndromes - drug therapy | Killer Cells, Natural - drug effects | Mycoses - complications | Mycoses - immunology | Infant | Killer Cells, Natural - pathology | Lymphoproliferative Disorders - immunology | Bacterial Infections - complications | Bacterial Infections - immunology | Killer Cells, Natural - immunology | Adult | Female | Registries | Steroids - therapeutic use | T-Lymphocytes - pathology | Immunologic Deficiency Syndromes - diagnosis | Diagnosis, Differential | Immunologic Deficiency Syndromes - complications | Lymphoproliferative Disorders - diagnosis | Opportunistic Infections - drug therapy | Lymphoproliferative Disorders - drug therapy | Leishmaniasis - complications | Immunologic Factors - therapeutic use | Index Medicus | Medicin och hälsovetenskap
Journal Article
2001, World Bank technical paper, ISBN 0821349643, Volume no. 510, vii, 63
Tuberculosis | AIDS (Disease) | PUBLIC HEALTH CARE | CRIME | PHYSIOTHERAPY | HIV INFECTIONS | VICTIMS | BUDGETARY ALLOCATIONS | CITIZENS | EMIGRATION | WASTE | DRUG USERS | HEALTH SECTOR | ALCOHOL | INCOME DISTRIBUTION | REPUBLICS | REHABILITATION | HOMELESSNESS | FISCAL | PRISONS | BIRTH RATE | PRIMARY SCHOOLS | AIR | RESOURCE DISTRIBUTION | AUTHORITY | DECENTRALIZATION | STATE BUDGETS | FOREIGN EXCHANGE | HEALTH SERVICES | URBAN AREAS | GIRLS | NATIONS | MORTALITY | PUBLIC HEALTH | PATIENTS | TUBERCULOSIS | HOSPITALS | PHC | SOCIAL CAPITAL | INSTITUTIONAL ARRANGEMENTS | INCOME | MIGRANTS | SCREENING | AGED | SOCIAL POLICY | PROSTITUTION | HEALTH INSURANCE | STIS | FINANCIAL CRISIS | HIV | ADOLESCENTS | HEALTH EXPENDITURES | SOCIOECONOMIC CONDITIONS | COMMUNIST | PRIMARY HEALTH CARE | SURGERY | TUBERCULOSIS PREVENTION | DISEASE SURVEILLANCE | IMMUNOLOGIC DISEASES | LIVING STANDARDS | PER CAPITA EXPENDITURES | GONORRHEA | MORTALITY RATES | DISEASE PREVENTION & CONTROL | INSOLVENCY | BUDGETARY RESOURCES | PUPILS | IMMIGRATION | LIFE EXPECTANCY | VENEREAL DISEASES | INFECTIOUS DISEASES | DECREE | LABOR MARKET | DRUG RESISTANT DISEASES | RISK GROUPS | PRIME MINISTERS | DISEASE TRANSMISSION | FISCAL DEFICIT | HEALTH STATUS | SEXUALLY TRANSMITTED INFECTIONS | ACQUIRED IMMUNE DEFICIENCY SYNDROME | SYPHILIS | SMOKING | HEALTH FACILITIES | UNEMPLOYMENT | INSOLVENCY SYSTEMS | PHARMACEUTICAL INDUSTRY | DEPRESSION | WORLD HEALTH ORGANIZATION | YOUNG ADULTS AUTOIMMUNE DISEASES | FOREIGN DIRECT INVESTMENT | HIV INFECTION | DISEASE VECTORS | FOREIGN TRADE | PUBLIC EXPENDITURES | HEALTH CARE | ECONOMICS | EPIDEMICS | ALCOHOLISM | EPIDEMIOLOGY
Book
1996, Lung biology in health and disease, ISBN 0824794036, Volume 87., xvii, 316
Book
1991, ISBN 0309044286, x, 146
Book
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 2, pp. 163 - 170
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Immunologic Deficiency Syndromes - pathology | Primary Myelofibrosis - drug therapy | Receptors, CXCR4 - antagonists & inhibitors | Humans | Middle Aged | Male | Primary Myelofibrosis - pathology | Warts - drug therapy | Bone Marrow Examination | Warts - pathology | Phenotype | Neoplasms, Squamous Cell - genetics | Bone Marrow - pathology | Neoplasms, Squamous Cell - drug therapy | Fatal Outcome | Receptors, CXCR4 - genetics | Immunologic Deficiency Syndromes - drug therapy | Heterocyclic Compounds - therapeutic use | Immunological deficiency syndromes | Genetic aspects | Research | Gene mutations | Drug therapy | Chemokine receptors | Laboratories | Reconstructive surgery | Infections | Hypogammaglobulinemia | Human papillomavirus | Granulocytes | Granulocyte colony-stimulating factor | Lymphocytes | Surgery | Bone marrow | Colony-stimulating factor | Drug dosages | Age | Neutropenia | Thrombocytopenia | Immunoglobulins | Myelofibrosis | Bacterial infections | Anemia | Neutrophils | Immunodeficiency | FDA approval | Patients | Lymphoma | CXCR4 protein | Quality of life | Warts | Ostomy | Chemotherapy | Infectious diseases | Mutation | Leukocytes (granulocytic) | Chemokines | Index Medicus | Abridged Index Medicus
Journal Article
2007, In-formation series, ISBN 0691130086, xii, 466
Book
Nature immunology, ISSN 1529-2908, 12/2016, Volume 17, Issue 12, pp. 1352 - 1360
Life Sciences & Biomedicine | Immunology | Science & Technology | RNA, Small Interfering - genetics | Humans | Actins - metabolism | Male | Thalidomide - pharmacology | Cell Movement - genetics | Thalidomide - analogs & derivatives | DNA Mutational Analysis | T-Lymphocytes - drug effects | HEK293 Cells | Killer Cells, Natural - immunology | Female | Child | Dyneins - metabolism | Cytotoxicity, Immunologic - genetics | Cell Proliferation - genetics | Guanine Nucleotide Exchange Factors - genetics | Lenalidomide | Jurkat Cells | Angiogenesis Inhibitors - pharmacology | DNA-Binding Proteins - genetics | Mutation - genetics | B-Lymphocytes - drug effects | Cell Movement - drug effects | B-Lymphocytes - immunology | Pedigree | Adolescent | Cytoskeleton - metabolism | Immunologic Deficiency Syndromes - genetics | T-Lymphocytes - immunology | Immunologic Deficiency Syndromes - drug therapy | Killer Cells, Natural - drug effects | Immunoglobulin Class Switching - genetics | Case studies | Ras genes | Causes of | Cytoskeleton | Immunological deficiency syndromes | Drug therapy | Pediatric research | Health aspects | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2015, Volume 137, Issue 1, pp. 223 - 230
Allergy and Immunology | autoimmunity | LPS-responsive beige-like anchor protein | common variable Immunodeficiency | enteropathy | primary immunodeficiency | lymphoproliferation | hypogammaglobulinemia | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Immunologic Deficiency Syndromes - therapy | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Hematopoietic Stem Cell Transplantation | Infant | Male | Phenotype | B-Lymphocytes - immunology | Adaptor Proteins, Signal Transducing - deficiency | Adaptor Proteins, Signal Transducing - genetics | Adolescent | Immunologic Deficiency Syndromes - metabolism | Female | T-Lymphocytes - immunology | Immunologic Deficiency Syndromes - drug therapy | Mutation | Adaptor Proteins, Signal Transducing - metabolism | Immunologic Deficiency Syndromes - immunology | Child | Medical colleges | Developmental biology | Children's hospitals | Immunodeficiency | Stem cells | College graduates | Jewish schools | Genetic aspects | Cross infection | Transplantation | Nosocomial infections | Autoimmunity | Proteins | Inflammatory bowel disease | Genotype & phenotype | Rodents | Protein expression | Infections | Kinases | Patients | Apoptosis | Siblings | Index Medicus | Abridged Index Medicus
Journal Article
Annual review of immunology, ISSN 0732-0582, 3/2015, Volume 33, Issue 1, pp. 291 - 353
calcium | potassium | STIM | transporters | magnesium | K | TRP, T cells, B cells, macrophages, mast cells, DC, disease, therapy | ion channels | CRAC | ORAI | sodium | V | 1.3 | 3.1 | chloride | zinc | Ca | Therapy | KV1.3 | Calcium | Disease | B cells | Macrophages | T cells | Zinc | Chloride | TRP | Sodium | KCa3.1 | Transporters | Ion channels | Mast cells | Magnesium | Potassium | Immunotherapy - methods | Calcium Channels - metabolism | Humans | Hypersensitivity - immunology | Ion Channels - genetics | Molecular Targeted Therapy | Lymphocytes - immunology | Hypersensitivity - metabolism | Cation Transport Proteins - metabolism | Immunity, Innate - physiology | Mast Cells - metabolism | Cation Transport Proteins - genetics | Hypersensitivity - genetics | Immunologic Deficiency Syndromes - immunology | Calcium Channels - genetics | Lymphocytes - metabolism | Mast Cells - immunology | Adaptive Immunity - physiology | Signal Transduction | Lymphocytes - cytology | Animals | Ion Channels - metabolism | Immunologic Deficiency Syndromes - genetics | Immunologic Deficiency Syndromes - metabolism | Immunologic Deficiency Syndromes - drug therapy | Mutation | Protein research | Cell research | Immune response | Cellular signal transduction | Research | Health aspects | Index Medicus | disease | therapy | mast cells | macrophages | DC
Journal Article